rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-11-23
|
pubmed:databankReference |
|
pubmed:abstractText |
To determine the effect of oral testosterone supplementation on systemic low-grade inflammation measured by high-sensitive C-reactive protein (hs-CRP) in aging men with low testosterone levels.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1097-6744
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
154
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1228.e1-7
|
pubmed:meshHeading |
pubmed-meshheading:18035098-Administration, Oral,
pubmed-meshheading:18035098-Aged,
pubmed-meshheading:18035098-Aged, 80 and over,
pubmed-meshheading:18035098-C-Reactive Protein,
pubmed-meshheading:18035098-Double-Blind Method,
pubmed-meshheading:18035098-Humans,
pubmed-meshheading:18035098-Inflammation,
pubmed-meshheading:18035098-Male,
pubmed-meshheading:18035098-Middle Aged,
pubmed-meshheading:18035098-Testosterone
|
pubmed:year |
2007
|
pubmed:articleTitle |
Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.
|
pubmed:affiliation |
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|